CROMSOURCE Appoints Chief Medical Officer and Expands Medical Affairs Services

PR65624

VERONA, Italy, Sept. 7 /PRNewswire=KYODO JBN/ --

      CROMSOURCE, an international contract research organization (CRO)

providing a comprehensive portfolio of services to the pharmaceutical,

biotechnology, and medical device industries, announced today the appointment

of its new Chief Medical Officer, Dr. Grzegorz Rychlik, and the expansion of

its Medical Affairs Services department.

    (Logo: http://photos.prnewswire.com/prnh/20151005/273774LOGO)

    Dr. Rychlik has more than 26 years of experience in the pharmaceutical

industry. He has held positions of increasing responsibility with sponsor and

service companies of various sizes, including large, global organizations such

as Pfizer, Novartis, and Parexel,  as well as virtual, small, and mid-sized

enterprises.  Dr. Rychlik's most recent position was Managing Director with

MRCD Pharma Services Ltd in the United Kingdom, and prior to that he served as

Medical Director and Chief Medical Officer for various organizations. His

therapeutic expertise is closely aligned with CROMSOURCE's key areas of focus

and expertise, namely Oncology, Ophthalmology, Respiratory, Cardiovascular,

CNS, and Medical Devices.

    "The addition of an experienced and respected medical professional such as

Greg strongly positions CROMSOURCE to be able to further support the

increasingly complex product development needs of our clients. Additionally, as

we expand our Medical Affairs offering we will optimize and grow our

consultancy and medical services to better serve our clients," stated Dr.

Oriana Zerbini, Founder and Chief Executive Officer of CROMSOURCE.

    Dr. Troy McCall, CROMSOURCE Chief Operating Officer, added, "We are very

pleased to have Dr. Rychlik join the CROMSOURCE team. Under his leadership,

CROMSOURCE will expand our Medical Monitoring, Pharmacovigilance, and Medical

Writing services to meet growing client needs. Having highly experienced and

skilled individuals such as Greg within the Medical Affairs Services group will

allow for the optimization and standardization of interdependent processes,

while leveraging efficiencies and ensuring that the highest level of quality is

delivered."

    About CROMSOURCE

    CROMSOURCE is an ISO-certified, international contract research

organization providing a comprehensive portfolio of services to the

pharmaceutical, biotechnology, and medical device industries.  Specializing in

clinical development and staffing solutions they offer a flexible approach to

ensure their clients' unique needs are supported. CROMSOURCE is unparalleled in

offering an end-to-end guarantee covering trial timelines, enrollment, and

contract price.  This guarantees their clients that trials are delivered

on-time and within the contract price with no CRO-initiated change orders.

CROMSOURCE operates offices across all regions of Europe and North America. For

more information, visit http://www.cromsource.com.

SOURCE: CROMSOURCE